During the two years following cART initiation, non-R5 patients experienced a greater increase of CD4 cell count than R5 patients, nevertheless non-R5 patients appeared to maintain a lower CD4/CD8 ratio which signifies a persistent immune dysregulation and ongoing inflammatory processes, possibly leading to increased non-AIDS-related morbidity and mortality. Here, CD4 is linked to AIDS.